GLP1R and diabetes mellitus: Glucagon-like peptide receptor-1 agonists (GLP-1RA) and dipeptidyl peptidase-4 inhibitors (DPP-4i) are classes of antidiabetic medications that are used in the management of DM mimicking the action of incretin hormones [8, 9].